Article Details

Biopharma Sees 37% More VC Financing, but Fewer Deals, in Q1

Retrieved on: 2018-04-10 22:26:15

Tags for this article:

Click the tags to see associated articles and topics

Biopharma Sees 37% More VC Financing, but Fewer Deals, in Q1. View article details on hiswai:

Excerpt

<div>Moderna raised the financing from a global group of new investors that included EDBI, the dedicated corporate investment arm of the Singapore Economic Development Board; a wholly-owned subsidiary of the Abu Dhabi Investment Authority; BB Biotech; Julius Baer; and <b>Sequoia Capital</b> China.</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo